The Simpsons writer Steve Pepoon has died following a two-year battle with a rare heart condition called cardiac amyloidosis, ...

Intellia's CRISPR therapy nexiguran ziclumeran maintained reductions in the levels of a misfolded protein in the nerves of ...

The journalist’s organs had been severely damaged by the disease, which causes a buildup of amyloid proteins in the body.

The Chattanooga Heart Institute at CHI Memorial announced the opening a new center aimed at detecting and treating an often ...

A woman has shared the insights to a rare heart condition called amyloidosis that her husband suffered from, following the ...

Intellia Therapeutics (NTLA) announced positive two-year follow-up data from the ongoing Phase 1 trial of investigational nexiguran ziclumeran, ...

Alnylam Pharmaceuticals (NASDAQ:ALNY) on Saturday released additional data from its Phase 3 HELIOS-B trial, which evaluated ...

In a follow up to his recent appearance on the Business of Biotech, Tolga Tanguler explains how Alnylam is positioning ...

While the results bolster efficacy, questions remain about high costs and other issues with the ATTR-CM therapies.

gene in liver cells, thereby preventing the production of transthyretin (TTR) protein for the treatment of ATTR amyloidosis. Nex-z offers the possibility of halting and reversing the disease by ...

Another unfortunate event brings that The Simpsons writer Steve Pepoon has left the world on May 3. The fame, aged 68, was ...

Steve Pepoon, an Emmy-winning writer for 'The Simpsons', died at 68 after battling cardiac amyloidosis. Pepoon's legacy ...